BRIEF published on 11/14/2024 at 08:21, 9 days 1 hour ago Verbio Applauds Cabinet's Move on GHG Quota Surplus Verbio SE GHG Quota Federal Cabinet CO2 Surplus Biodiesel Fraud
PRESS RELEASE published on 11/14/2024 at 08:16, 9 days 1 hour ago Verbio SE: Measures to counter GHG quota surpluses: Verbio welcomes cabinet resolution Verbio SE welcomes the Federal cabinet resolution to counter GHG quota surpluses, leading to increased demand for quota fulfilment options and supporting GHG quota prices in 2025 and 2026 Verbio SE Carbon Emissions GHG Quotas Cabinet Resolution Quota Surpluses
BRIEF published on 11/12/2024 at 08:05, 11 days 1 hour ago Verbio Reports Challenges in Q1 2024/25; Anticipates Recovery EBITDA Q1 2024/25 Verbio GHG Quotas Biofuels
PRESS RELEASE published on 11/12/2024 at 08:00, 11 days 1 hour ago Verbio SE: Challenging market conditions in Q1 2024/25; optimistic outlook for HY 2 2024/25 Verbio SE reports challenging market conditions in Q1 2024/25 with lower EBITDA, but anticipates improved results in HY 2 2024/25. Positive outlook supported by BMUV draft paper EBITDA Market Conditions Verbio SE Q1 2024/25 BMUV Draft Paper
BRIEF published on 09/26/2024 at 08:05, 1 month 27 days ago Verbio Achieves Forecast Earnings and Highlights Key Milestones in FY 2023/24 Financial Results EBITDA Strategic Investments Future Outlook Production Milestones
PRESS RELEASE published on 09/26/2024 at 08:00, 1 month 27 days ago Verbio SE: Verbio achieves forecast earnings in FY 2023/24 and marks important milestones Verbio SE achieves forecast earnings in FY 2023/24, with EBITDA of EUR 121.6 million, and marks strategic milestones in biodiesel, bioethanol, and biomethane production EBITDA Verbio SE Strategic Milestones Forecast Earnings Bio-based Chemicals
BRIEF published on 09/10/2024 at 19:37, 2 months 12 days ago VERBIO SE Projects Lower-than-Expected EBITDA for Financial Year 2024/25 EBITDA Forecast Annual Report Bioethanol/Biomethane Growth European Market Outlook Net Debt Increase
PRESS RELEASE published on 09/10/2024 at 19:32, 2 months 12 days ago EQS-Adhoc: Verbio SE: Verbio forecasts EBITDA of EUR 120 million to EUR 160 million for the financial year 2024/25 Verbio SE forecasts EBITDA of EUR 120-160 million for the financial year 2024/25 based on expected sales, production capacity, and market conditions EBITDA Financial Year Forecast Verbio SE 2024/25
BRIEF published on 07/22/2024 at 16:12, 4 months ago Verbio Welcomes Decision on Anti-Dumping Proceedings European Commission Verbio Biodiesel Anti-dumping GHG Quotas
PRESS RELEASE published on 07/22/2024 at 16:07, 4 months ago Verbio welcomes the preliminary results of anti-dumping proceedings Verbio welcomes EU's anti-dumping tariffs on Chinese biodiesel & HVO, addressing unfair trade practices in biofuels industry. Verbio emphasizes sustainability & long-term solutions Sustainability Tariffs Verbio Anti-dumping Biofuels
Published on 11/22/2024 at 23:55, 9 hours 32 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 57 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 22 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 57 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 33 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 31 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 27 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
